PHR — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

8.93

Margin Of Safety %

Put/Call OI Ratio

0.38

EPS Next Q Diff

0.24

EPS Last/This Y

1.47

EPS This/Next Y

0.28

Price

8.75

Target Price

17.37

Analyst Recom

1.6

Performance Q

-49.25

Upside

-88.0%

Beta

0.87

Ticker: PHR

21 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	PHR	12.07	0.47	0.05	8529
2026-03-10	PHR	11.75	0.47	0.14	8567
2026-03-11	PHR	11.34	0.47	0.14	8621
2026-03-12	PHR	11.01	0.46	2.50	8656
2026-03-13	PHR	11	0.46	2.25	8656
2026-03-17	PHR	11.21	0.45	0.01	8660
2026-03-18	PHR	11.2	0.45	0.16	8661
2026-03-19	PHR	11.75	0.44	0.00	8920
2026-03-20	PHR	11.86	0.43	0.09	8971
2026-03-23	PHR	11.78	0.42	0.10	9012
2026-03-24	PHR	11.28	0.42	0.79	9080
2026-03-25	PHR	11.28	0.42	2.00	9161
2026-03-26	PHR	11.66	0.43	0.01	9175
2026-03-27	PHR	10.98	0.42	0.15	9284
2026-03-30	PHR	11.39	0.42	0.20	9374
2026-03-31	PHR	8.37	0.40	0.79	9894
2026-04-01	PHR	8.4	0.43	0.08	12488
2026-04-02	PHR	8.37	0.41	0.05	12840
2026-04-06	PHR	9.16	0.40	0.07	12853
2026-04-07	PHR	9.06	0.38	0.04	12888
2026-04-08	PHR	8.76	0.38	0.09	12815
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	PHR	12.06	72.2	-	1.17
2026-03-10	PHR	11.75	72.2	-	1.17
2026-03-11	PHR	11.33	72.2	-	1.17
2026-03-12	PHR	11.00	72.2	-	1.17
2026-03-13	PHR	10.97	72.2	-	1.17
2026-03-17	PHR	11.19	72.2	-	1.17
2026-03-18	PHR	11.21	72.2	-	1.17
2026-03-19	PHR	11.79	72.2	-	1.17
2026-03-20	PHR	11.86	72.2	-	1.17
2026-03-23	PHR	11.80	72.2	-	1.17
2026-03-24	PHR	11.28	72.2	-	1.17
2026-03-25	PHR	11.27	72.2	-	1.17
2026-03-26	PHR	11.64	72.2	-	1.17
2026-03-27	PHR	10.99	72.2	-	1.17
2026-03-30	PHR	11.42	72.2	-	1.17
2026-03-31	PHR	8.34	72.2	-	1.17
2026-04-01	PHR	8.40	72.2	-	1.17
2026-04-02	PHR	8.36	72.2	-	1.17
2026-04-06	PHR	9.14	53.0	-	1.51
2026-04-07	PHR	9.06	53.0	-	1.51
2026-04-08	PHR	8.75	53.0	-	1.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	PHR	-1.03	-3.32	7.07
2026-03-10	PHR	-1.03	-3.32	7.07
2026-03-11	PHR	-1.03	-3.32	7.43
2026-03-12	PHR	-1.03	-3.32	7.43
2026-03-13	PHR	-1.03	-3.32	7.43
2026-03-17	PHR	-1.03	-3.40	7.43
2026-03-18	PHR	-1.03	-3.40	7.43
2026-03-19	PHR	-0.81	-3.40	7.43
2026-03-20	PHR	15.41	-3.40	7.43
2026-03-23	PHR	15.39	-3.38	7.43
2026-03-24	PHR	15.39	-3.38	7.43
2026-03-25	PHR	15.32	-3.38	9.00
2026-03-26	PHR	15.32	-3.38	9.00
2026-03-27	PHR	15.28	-3.38	9.00
2026-03-30	PHR	15.28	-3.37	9.00
2026-03-31	PHR	15.28	-3.37	9.00
2026-04-01	PHR	15.28	-3.37	9.00
2026-04-02	PHR	15.28	-3.37	9.00
2026-04-06	PHR	32.14	-3.46	8.93
2026-04-07	PHR	32.14	-3.46	8.93
2026-04-08	PHR	32.15	-3.46	8.93
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.12

Avg. EPS Est. Current Quarter

0.35

Avg. EPS Est. Next Quarter

0.36

Insider Transactions

32.15

Institutional Transactions

-3.46

Beta

0.87

Average Sales Estimate Current Quarter

135

Average Sales Estimate Next Quarter

136

Fair Value

15.56

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

88.5

Max Drawdown 5-Year %

-88.8

Target Price

17.37

P/E

252.89

Forward P/E

14.92

PEG

0.09

P/S

1.11

P/B

1.57

P/Free Cash Flow

8.24

EPS

0.03

Average EPS Est. Cur. Y

1.51

EPS Next Y. (Est.)

1.78

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

0.48

Relative Volume

0.91

Return on Equity vs Sector %

-26.6

Return on Equity vs Industry %

-8.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ PHR Healthcare

$8.75

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

12/20

Pullback

12/25

Volume

4/15

Valuation

18/20

TP/AR

1/10

Options

6/10

RSI

31.3

Range 1M

20.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

27/30

Estimates

3/20

Inst/Vol

1/15

Options

10/10

EPS Yr

704.3%

EPS NY

82.3%

52W%

3.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +349% upside

Quality

6/30

Valuation

28/30

Growth

20/25

Stability

6/10

LT Trend

4/5

Upside

+349%

Quality

MoS

78%

Phreesia, Inc.

Sector: Healthcare

Industry: Health Information Services

Employees: 1789

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. It offers solutions including appointment optimization and referral management using AI-enabled workflows; and AI-based smart answering solution patient communications supported by voice and messaging solutions; integrated payment solutions embedded in intake and post-visit workflows, and financing solutions that enable healthcare organizations to accelerate cash collections while offering flexible payment options to patients; and digital intake and clinical data capture, patient engagement and activation tools, and measurement and analytics solutions. It also offers PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, which are on-site kiosks. The company serves a range of healthcare organizations including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest and not-for-profit and other organizations. Phreesia, Inc. was incorporated in 2005 and is based in Wilmington, Delaware.

PHR

Latest News

—

Caricamento notizie per PHR…

stock quote shares PHR – Phreesia, Inc. Stock Price stock today

news today PHR – Phreesia, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch PHR – Phreesia, Inc. yahoo finance google finance

stock history PHR – Phreesia, Inc. invest stock market

stock prices PHR premarket after hours

ticker PHR fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: PHR

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y